Selective hypermethylation of transcribed nucleosomal DNA by sodium butyrate.
Previous studies have shown that treatment of cultured fibroblasts with millimolar concentrations of sodium butyrate results in increased methylation of cytosine residues in DNA. In this study, active nucleosomes were fractionated from the inactive ones by organomercurial agarose column chromatography. DNA in each fraction was hydrolyzed to its constituent bases and subjected to HPLC analysis in order to determine the 5-methylcytosine content. In control cells, the active nucleosomal DNA was hypomethylated (0.97 +/- 0.27% 5-methyleytosine) when compared with the inactive DNA fraction (1.61 +/- 0.15%). This result was not unexpected since DNA hypermethylation is generally associated with gene inactivation. Treatment of cells with sodium butyrate, however, resulted in increased methylation of the active nucleosomal DNA such that it was comparable to that of the inactive fraction of control cells (1.73 +/- 0.02% 5-methylcytosine). A much smaller increase in 5-methylcytosine content was detected in the inactive DNA fraction of sodium butyrate-treated cells (from 1.61 to 1.89%). Removal of the sodium butyrate followed by a chase in butyrate-free medium for up to 120 h failed to reverse the butyrate-induced hypermethylation. Reversal was achieved only after continuous culture in butyrate-free medium for 10 days.
Boffa
L C
LC
Department of Chemical Carcinogenesis, Istituto Nazionale per la Ricerca sul Cancro, IST, Genova, Italy.
Mariani
M R
MR
Parker
M I
MI
D002087:Butyrates / Q000494:pharmacology*; D020148:Butyric Acid; D004247:DNA / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism*; D006367:HeLa Cells; D006801:Humans; D008745:Methylation; D009707:Nucleosomes / Q000187:drug effects / Q000378:metabolism; D014158:Transcription, Genetic
D002087:Butyrates; D009707:Nucleosomes; D020148:Butyric Acid; D004247:DNA